Global Trust Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.83M | Buy |
30,219
+3,043
| +11% | +$177K | 0.7% | 39 |
|
|
2025
Q4 | $1.47M | Buy |
27,176
+26,275
| +2,916% | +$1.26M | 0.58% | 43 |
|
|
2025
Q3 | $40.6K | Hold |
901
| – | – | 0.02% | 293 |
|
|
2025
Q2 | $41.7K | Sell |
901
-800
| -47% | -$39.3K | 0.02% | 278 |
|
|
2025
Q1 | $104K | Sell |
1,701
-100
| -6% | -$5.83K | 0.06% | 194 |
|
|
2024
Q4 | $102K | Buy |
1,801
+600
| +50% | +$33.5K | 0.04% | 226 |
|
|
2024
Q3 | $62.1K | Sell |
1,201
-300
| -20% | -$14.1K | 0.02% | 272 |
|
|
2024
Q2 | $62.3K | Sell |
1,501
-150
| -9% | -$6.71K | 0.03% | 251 |
|
|
2024
Q1 | $89.5K | Sell |
1,651
-100
| -6% | -$5.09K | 0.04% | 228 |
|
|
2023
Q4 | $89.8K | Sell |
1,751
-2,329
| -57% | -$122K | 0.04% | 209 |
|
|
2023
Q3 | $237K | Hold |
4,080
| – | – | 0.11% | 131 |
|
|
2023
Q2 | $261K | Hold |
4,080
| – | – | 0.12% | 129 |
|
|
2023
Q1 | $283K | Sell |
4,080
-15
| -0.4% | -$1.06K | 0.13% | 125 |
|
|
2022
Q4 | $295K | Sell |
4,095
-15
| -0.4% | -$1.13K | 0.15% | 119 |
|
|
2022
Q3 | $292K | Sell |
4,110
-100
| -2% | -$7.25K | 0.15% | 113 |
|
|
2022
Q2 | $324K | Buy |
4,210
+1,603
| +61% | +$122K | 0.16% | 117 |
|
|
2022
Q1 | $190K | Buy |
2,607
+4
| +0.2% | +$269 | 0.08% | 182 |
|
|
2021
Q4 | $162K | Sell |
2,603
-102
| -4% | -$5.98K | 0.06% | 188 |
|
|
2021
Q3 | $160K | Buy |
2,705
+4
| +0.1% | +$263 | 0.07% | 181 |
|
|
2021
Q2 | $181K | Buy |
2,701
+4
| +0.1% | +$261 | 0.09% | 177 |
|
|
2021
Q1 | $170K | Buy |
2,697
+4
| +0.1% | +$249 | 0.09% | 167 |
|
|
2020
Q4 | $167K | Buy |
2,693
+1,983
| +279% | +$122K | 0.09% | 175 |
|
|
2020
Q3 | $42K | Buy |
710
+3
| +0.4% | +$181 | 0.03% | 206 |
|
|
2020
Q2 | $42K | Sell |
707
-9,006
| -93% | -$539K | 0.03% | 191 |
|
|
2020
Q1 | $528K | Buy |
9,713
+4,213
| +77% | +$258K | 0.41% | 68 |
|
|
2019
Q4 | $353K | Buy |
5,500
+4,500
| +450% | +$258K | 0.21% | 116 |
|
|
2019
Q3 | $51K | Sell |
1,000
-2,511
| -72% | -$118K | 0.03% | 196 |
|
|
2019
Q2 | $48K | Buy |
3,511
+2,511
| +251% | +$117K | 0.03% | 219 |
|
|
2019
Q1 | $48K | Sell |
1,000
-255
| -20% | -$12.7K | 0.04% | 211 |
|
|
2018
Q4 | $65K | Hold |
1,255
| – | – | 0.06% | 174 |
|
|
2018
Q3 | $78K | Hold |
1,255
| – | – | 0.05% | 194 |
|
|
2018
Q2 | $69K | Hold |
1,255
| – | – | 0.05% | 186 |
|
|
2018
Q1 | $79K | Hold |
1,255
| – | – | 0.06% | 174 |
|
|
2017
Q4 | $77K | Buy |
+1,255
| New | +$78.5K | 0.05% | 189 |
|
Other funds holding BMY
VCM
VPM
Global Trust Asset Management's BMY Position: Q1 2026 in Review
Global Trust Asset Management increased its Bristol-Myers Squibb (BMY) stake by 11% in Q1 2026, buying an estimated $177K and bringing the position to 30,219 shares worth $1.83M. The position accounts for 0.7% of the portfolio, ranked #39.
Global Trust Asset Management first reported a position in BMY in Q4 2017 and has held it in 34 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Global Trust Asset Management held 30,219 shares of Bristol-Myers Squibb worth $1.83M as of Q1 2026.
- Global Trust Asset Management bought 3,043 Bristol-Myers Squibb shares in Q1 2026, an estimated $177K.
- Bristol-Myers Squibb made up 0.7% of Global Trust Asset Management's portfolio in Q1 2026, its #39 holding.
- Global Trust Asset Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 34 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Global Trust Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.